These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2467737)
1. Cytogenetic analysis of four primary prostatic cultures. Brothman AR; Lesho LJ; Somers KD; Schellhammer PF; Ladaga LE; Merchant DJ Cancer Genet Cytogenet; 1989 Feb; 37(2):241-8. PubMed ID: 2467737 [TBL] [Abstract][Full Text] [Related]
2. Frequency and pattern of karyotypic abnormalities in human prostate cancer. Brothman AR; Peehl DM; Patel AM; McNeal JE Cancer Res; 1990 Jun; 50(12):3795-803. PubMed ID: 2340524 [TBL] [Abstract][Full Text] [Related]
4. Phenotypic and cytogenetic characterization of a cell line derived from primary prostatic carcinoma. Brothman AR; Lesho LJ; Somers KD; Wright GL; Merchant DJ Int J Cancer; 1989 Nov; 44(5):898-903. PubMed ID: 2583869 [TBL] [Abstract][Full Text] [Related]
5. Chromosomal aberrations in benign prostatic hyperplasia patients. Altok M; Bağcı Ö; Umul M; Güneş M; Akyüz M; Uruç F; Uz E; Soyupek S Investig Clin Urol; 2016 Jan; 57(1):45-9. PubMed ID: 26966725 [TBL] [Abstract][Full Text] [Related]
6. Chromosome changes in benign prostatic hyperplasia and their significance in the origin of prostatic carcinoma. Casalone R; Portentoso P; Granata P; Minelli E; Righi R; Meroni E; Pozzi E; Chiaravalli AM Cancer Genet Cytogenet; 1993 Jul; 68(2):126-30. PubMed ID: 7689034 [TBL] [Abstract][Full Text] [Related]
7. Defining the extent and nature of cytogenetic events in prostatic adenocarcinoma: paraffin FISH vs. metaphase analysis. Micale MA; Sanford JS; Powell IJ; Sakr WA; Wolman SR Cancer Genet Cytogenet; 1993 Aug; 69(1):7-12. PubMed ID: 8374904 [TBL] [Abstract][Full Text] [Related]
8. Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples. Festuccia C; Angelucci A; Gravina GL; Muzi P; Miano R; Vicentini C; Bologna M Int J Oncol; 2005 May; 26(5):1353-62. PubMed ID: 15809728 [TBL] [Abstract][Full Text] [Related]
9. [Chromosomal abnormalities in carcinoma and hyperplasia of the prostate]. Miyauchi T; Nagayama T; Maruyama K Nihon Hinyokika Gakkai Zasshi; 1992 Jan; 83(1):66-74. PubMed ID: 1373453 [TBL] [Abstract][Full Text] [Related]
10. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone. Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787 [TBL] [Abstract][Full Text] [Related]
11. Specific cytogenetic aberrations in two novel human prostatic cell lines immortalized by human papillomavirus type 18 DNA. Weijerman PC; van Drunen E; König JJ; Teubel W; Romijn JC; Schröder FH; Hagemeijer A Cancer Genet Cytogenet; 1997 Dec; 99(2):108-15. PubMed ID: 9398864 [TBL] [Abstract][Full Text] [Related]
12. Chromosomal anomalies in atypical adenomatous hyperplasia and carcinoma of the prostate using fluorescence in situ hybridization. Qian J; Jenkins RB; Bostwick DG Urology; 1995 Dec; 46(6):837-42. PubMed ID: 7502426 [TBL] [Abstract][Full Text] [Related]
13. Cytogenetics of primary prostatic adenocarcinoma. Clonality and chromosome instability. Micale MA; Mohamed A; Sakr W; Powell IJ; Wolman SR Cancer Genet Cytogenet; 1992 Jul; 61(2):165-73. PubMed ID: 1638499 [TBL] [Abstract][Full Text] [Related]
14. Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Lundgren R; Mandahl N; Heim S; Limon J; Henrikson H; Mitelman F Genes Chromosomes Cancer; 1992 Jan; 4(1):16-24. PubMed ID: 1377005 [TBL] [Abstract][Full Text] [Related]
15. Glycoprotein A-80 in the human prostate: immunolocalization in prostatic intraepithelial neoplasia, carcinoma, radiation failure, and after neoadjuvant hormonal therapy. Coogan CL; Bostwick DG; Bloom KJ; Gould VE Urology; 2003 Jan; 61(1):248-52. PubMed ID: 12559317 [TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions. Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263 [TBL] [Abstract][Full Text] [Related]